 agents
and a statin after intervention, both open and endovascular.139 The optimal antiplatelet agent regimen and
endovascular interventions for CMI remains unresolved.
Peeters Weem et al140 performed a meta-analysis to
examine the optimal antiplatelet regimen after endovascular arterial procedures. They did not support the use of
dual antiplatelet therapy (vs monotherapy) and actually
advised against it owing to an increased bleeding risk